Barinthus Biotherapeutics plc (BRNS) earnings · $38.2M cap
These earnings events as JSON? API free 100/dayBarinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
This BRNS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BRNS revenue for 2025-12-31 was $0. Net income was -$66.4M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. BRNS currently screens at market cap $38.2M.
When the next BRNS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BRNS research stays on the stock page; the tape stays on the quote page.
BRNS earnings FAQ
What is BRNS's latest net income?
Latest cached Barinthus Biotherapeutics plc (BRNS) net income was -$66.4M. Statements: https://lician.com/financials/brns
What is BRNS's latest diluted EPS?
Latest cached Barinthus Biotherapeutics plc (BRNS) diluted EPS for Dec 31, 2025 was -$1.64.
What period does the latest BRNS earnings print cover?
The latest cached Barinthus Biotherapeutics plc (BRNS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are BRNS earnings listed?
Cached earnings facts for Barinthus Biotherapeutics plc (BRNS) are listed at https://lician.com/earnings/brns. Statements: https://lician.com/financials/brns
Not investment advice.